Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension
Clinical trial NCT01785472 · COMPLETED
Trial details
- NCT number
- NCT01785472
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2014-08-01
- Enrollment
- 1438
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.